Home » Topics » BioWorld Science

BioWorld Science
RSS

Beta Pharma begins phase I/II study of BPI-1178 in advanced solid tumors and breast cancer

July 13, 2020

Australia's TGA grants provisional approval to remdesivir

July 13, 2020

Alzumab approved in India for emergency use to treat CRS in patients with COVID-19-related ARDS

July 13, 2020

Oragenics advances TerraCoV2, ends development of AG-013 for oral mucositis

July 13, 2020

BRAF inhibitor ABM-1310 displays potent efficacy in xenograft cancer models

July 13, 2020

Celldex Therapeutics starts enrollment in phase I study of CDX-527

July 13, 2020

Enrollment ongoing in phase I study of KBL-693

July 13, 2020

NBE-Therapeutics initiates phase I/II study of NBE-002

July 13, 2020

Aligos Therapeutics presents preclinical data on ALG-031048

July 13, 2020

First-in-human study of INV-1120

July 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...